Literature DB >> 11325602

X protein of hepatitis B virus modulates cytokine and growth factor related signal transduction pathways during the course of viral infections and hepatocarcinogenesis.

J Diao1, R Garces, C D Richardson.   

Abstract

Hepatitis B virus produces chronic infections of the liver leading to cirrhosis and hepatocellular carcinoma. The X protein of hepatitis B virus (HBx) is a multifunctional protein that can interact with p53 but can also influence a variety of signal transduction pathways within the cell. In most instances this small viral protein favors cell survival and probably initiates hepatocarcinogenesis. HBx upregulates the activity of a number of transcription factors including NF-kappa B, AP-1, CREB, and TBP. However, the majority of HBx is localized to the cytoplasm where it interacts with and stimulates protein kinases such as protein kinase C, Janus kinase/STAT, IKK, PI-3-K, stress-activated protein kinase/Jun N-terminal kinase, and protein kinase B/Akt. This small viral protein can localize to the mitochondrion. HBx may act as an adaptor or kinase activator to influence signal transduction pathways. This review will attempt to analyze the involvement of HBx in signal transduction pathways during hepatitis B viral infections and hepatocellular carcinoma development.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11325602     DOI: 10.1016/s1359-6101(00)00034-4

Source DB:  PubMed          Journal:  Cytokine Growth Factor Rev        ISSN: 1359-6101            Impact factor:   7.638


  38 in total

1.  Aggregate formation of hepatitis B virus X protein affects cell cycle and apoptosis.

Authors:  Chang-Zheng Song; Zeng-Liang Bai; Chang-Cheng Song; Qing-Wei Wang
Journal:  World J Gastroenterol       Date:  2003-07       Impact factor: 5.742

2.  Hepatic cell apoptosis was triggerred by HBx accumulation and independent on verapamil.

Authors:  Haiping Wang; Xiaoping Chen; Xiangjun Bai
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2004

3.  Anticancer potential of rhamnocitrin 4'-β-D-galactopyranoside against N-diethylnitrosamine-induced hepatocellular carcinoma in rats.

Authors:  Shakir Saleem; Md Adil Shaharyar; Mohammad Jawed Khusroo; Parwej Ahmad; Rais Ur Rahman; Kamran Ahmad; Md Jahangir Alam; Naif O Al-Harbi; Muzaffar Iqbal; Faisal Imam
Journal:  Mol Cell Biochem       Date:  2013-09-12       Impact factor: 3.396

4.  Dynamic expression of ZNF382 and its tumor-suppressor role in hepatitis B virus-related hepatocellular carcinogenesis.

Authors:  Siwen Dang; Jingshi Zhou; Yijun Chen; Pu Chen; Meiju Ji; Bingyin Shi; Qi Yang; Peng Hou
Journal:  Oncogene       Date:  2019-02-25       Impact factor: 9.867

5.  Separate origins of hepatitis B virus surface antigen-negative foci and hepatocellular carcinomas in transgenic HBsAg (alb/psx) mice.

Authors:  Dana R Crawford; Stephanie Ostrowski; Dilip Vakharia; Zoran Ilic; Stewart Sell
Journal:  Am J Pathol       Date:  2006-07       Impact factor: 4.307

Review 6.  Viruses and human cancers: a long road of discovery of molecular paradigms.

Authors:  Martyn K White; Joseph S Pagano; Kamel Khalili
Journal:  Clin Microbiol Rev       Date:  2014-07       Impact factor: 26.132

7.  Hepatitis B virus X gene induces human telomerase reverse transcriptase mRNA expression in cultured normal human cholangiocytes.

Authors:  Sheng-Quan Zou; Zhen-Liang Qu; Zhan-Fei Li; Xin Wang
Journal:  World J Gastroenterol       Date:  2004-08-01       Impact factor: 5.742

Review 8.  Viruses associated with human cancer.

Authors:  Margaret E McLaughlin-Drubin; Karl Munger
Journal:  Biochim Biophys Acta       Date:  2007-12-23

9.  Overexpression of HBxAg in hepatocellular carcinoma and its relationship with Fas/FasL system.

Authors:  Xiao-Zhong Wang; Xiao-Chun Chen; Yun-Xin Chen; Li-Juan Zhang; Dan Li; Feng-Lin Chen; Zhi-Xin Chen; Hong-Ying Chen; Qi-Ming Tao
Journal:  World J Gastroenterol       Date:  2003-12       Impact factor: 5.742

10.  Hepatitis B virus X protein upregulates HSP90alpha expression via activation of c-Myc in human hepatocarcinoma cell line, HepG2.

Authors:  Weihua Li; Xiaohui Miao; Zhongtian Qi; Wenting Zeng; Jianxin Liang; Zengwei Liang
Journal:  Virol J       Date:  2010-02-20       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.